drugset / Trial / NCT04270552

Efficacy Of Bacterial Lysate In Children With Allergic Rhinitis

NCT04270552 ↗

Phase 3 Completed 76 enrolled Medical University of Lublin
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This study evaluate the efficacy of Polyvalent Mechanical Bacterial Lysate (PMBL - Ismigen) to improve the clinical course of grass pollen-induced allergic rhinitis (using: TNSS, TOSS, VAS, PNIF) in children aged 5 to 17. Half of the 70 participants will receive PMBL while the other half will receive placebo.

Timeline

Start
2018-04-22
Primary completion
2018-07-20
Completion
2018-08-12

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Ismigen Vaccine 7 mg Other